Stay informed with the latest litigation news. Explore now

IP Verse

Pharmacyclics competitive analysis

Latest publications and patents of Pharmacyclics New

Explore the latest publications and patents granted to Pharmacyclics, showcasing their recent innovations and technological advancements.

Last updated on: Sep 7, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Pharmacyclics
EP3265084	Nov 22, 2023	Pharmaceutical Formulations Of Bruton'S Tyrosine Kinase Inhibtor	Granted And Under Opposition
EP3033079	Oct 31, 2018	Methods For The Treatment Of Her2 Amplified Cancer	Revoked
EP2529622	Jan 17, 2018	Inhibitors Of Bruton'S Tyrosine Kinase	Revoked

Latest patents of Pharmacyclics opposed by its competitors

Explore Pharmacyclics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3265084	Nov 22, 2023	Pharmaceutical Formulations Of Bruton'S Tyrosine Kinase Inhibtor	1
EP3033079	Oct 31, 2018	Methods For The Treatment Of Her2 Amplified Cancer	1
EP2529622	Jan 17, 2018	Inhibitors Of Bruton'S Tyrosine Kinase	1

Latest PTAB cases involving Pharmacyclics New

Discover the latest PTAB cases involving Pharmacyclics, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 13, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Pharmacyclics
PGR2024-00009	Nov 1, 2023	BEIGENE USA	PHARMACYCLICS	Final Written Decision
IPR2019-00865	Mar 21, 2019	SANDOZ	PHARMACYCLICS	Final Written Decision
IPR2015-01076	Apr 20, 2015	COALITION FOR AFFORDABLE DRUGS IV	PHARMACYCLICS	Institution Denied

Top competitors of Pharmacyclics

Top competitors of Pharmacyclics based on patent oppositions.

GENERICS UK

TEVA PHARMACEUTICALS